Chemical formula: C₈₂H₁₀₃ClN₁₈O₁₆ Molecular mass: 1,632.29 g/mol PubChem compound: 16136245
Degarelix is indicated for:
Population group: men, only adults (18 years old or older)
Degarelix is a gonadotrophin releasing hormone (GnRH) antagonist indicated for treatment of adult male patients with advanced hormone-dependent prostate cancer.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
